Latest Anti-diabetic medication Stories
CARLSBAD, Calif., Feb. 3, 2015 /PRNewswire/ -- Isis Pharmaceuticals, Inc.
According to Yale researchers, the likelihood of metformin resulting in the serious condition lactic acidosis in patients with mild to moderate kidney disease is extremely low--comparable to the risk in those who did not take metformin.
Forxiga® (dapagliflozin) approved in Canada - a new treatment that lowers blood glucose and can lead to weight loss(i) and reduced blood pressure for adults living with type 2 diabetes (ii)
The Firm is evaluating Byetta lawsuits and other product liability claims on behalf of individuals who allegedly developed pancreatic cancer, pancreatitis or thyroid cancer caused by incretin
The Lack of Reimbursement for DPP-IV Inhibitors and GLP-1 Analogues Hinders Their Uptake Among Chinese Patients, According to Findings from Decision Resources Group BURLINGTON, Mass., Dec.
ResearchMoz.us include new market research report "Global Diabetes Market 2014 Edition" to its huge collection of research reports.Browse latest reports from ResearchMoz at:
The Firm is evaluating Byetta lawsuits and other product liability claims on behalf of individuals who allegedly developed pancreatic cancer, pancreatitis or thyroid cancer after taking incretin
Expresses Continued Confidence in ACTOS DEERFIELD, Ill. and OSAKA, Japan, Nov.
- Intarcia grants Servier exclusive rights to ITCA 650 in ex-U.S./Japan territories; Intarcia retains full control of ITCA 650 in the United States and plans another partner in Japan.
Once-weekly treatment for adults with type 2 diabetes comes in a pen with a no-see, no-handle needle INDIANAPOLIS, Nov.
- a study of the individuals in a group of people within a specific context and their relationships.
- In rhetoric, the description of any one's personal appearance.